PODESTA GROUP, INC. for GENENTECH
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Kennedy American Affordable Health Choices Act of 2009 H.R. 3200 American Affordable Health Choices Act of 2009 Tri Caucus Healthcare Reform Bill Baucus/Finance Healthcare Reform Bill - America's Healthy Future Act of 2009 S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient-Centered Outcomes Research Act of 2009 S. 301 Physican Payments Sunshine Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | Executive Director, Congressional Black Caucus |
| SHARON COHEN | — |
| ANDREW KAUDERS | Senior Advisor, Sen. Robert Menendez |
| ANTHONY PODESTA | — |
| NICOLE C YOUNG | — |
Medicare/Medicaid MMM
Medicare Issues Comparative Effectiveness S. 301 Physician Payments Sunshine Act of 2009 H.R. 2939 Oncology Quality Care Improvement Act Kennedy American Affordable Health Choices Act of 2009 H.R. 3200 American Affordable Health Choices Act of 2009 Tri Caucus Healthcare Reform Bill Baucus/Finance Healthcare Reform Bill - America's Healthy Future Act of 2009 S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient-Centered Outcomes Research Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | Executive Director, Congressional Black Caucus |
| SHARON COHEN | — |
| ANDREW KAUDERS | Senior Advisor, Senator Robert Menendez |
| ANTHONY PODESTA | — |
| NICOLE C YOUNG | — |
Budget/Appropriations BUD
H. R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85 Comparative Effectiveness
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | Executive Director, Congressional Black Caucus |
| SHARON COHEN | — |
| ANTHONY PODESTA | — |
| NICOLE C YOUNG | — |
Medical/Disease Research/Clinical Labs MED
LHHS Appropriations (CMS and comparative effectiveness related matters)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | Executive Director, Congressional Black Caucus |
| SHARON COHEN | — |
| NICOLE C YOUNG | — |
Copyright/Patent/Trademark CPT
H.R. 1260 Patent Reform Act of 2009 S. 515 Patent Reform Act of 2009 S. 610 Patent Reform Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | Executive Director, Congressional Black Caucus |
| SHARON COHEN | — |
| CLAUDIA JAMES | — |
| ANTHONY PODESTA | — |
| NICOLE C YOUNG | — |
Pharmacy PHA
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act of 2009 S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TEAL BAKER | Executive Assistant Rep. Brian Baird |
| PAUL BRATHWAITE | Executive Director, Congressional Black Caucus |
| SHARON COHEN | — |
| ANDREW KAUDERS | Senior Advisor, Senator Robert Menendez |
| ELIZABETH ANN MORRA | — |
| ANTHONY PODESTA | — |
| THOMAS B SPARKMAN | Health Policy Intern, Senate HELP Committee |
| NICOLE C YOUNG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.